Skip to content
healthcare.dev

Topiramate

NDC 69097-818, Topiramate, tablet, from Cipla USA Inc..

Product NDC
69097-818
Status
Listed
Labeler
Cipla USA Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA079162
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69097-818 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TOPIRAMATE100 mg/1

Pharmacologic classes

Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
69097-818-036909708180360 TABLET in 1 BOTTLE (69097-818-03)
69097-818-1269097081812500 TABLET in 1 BOTTLE (69097-818-12)
69097-818-15690970818151000 TABLET in 1 BOTTLE (69097-818-15)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4087eb3c-96e9-4d0a-b80b-663e1c86d256

Use it

Look up 69097-818 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69097-818 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69097-818. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.